Innate Pharma (IPHA) Non-Current Assets (2017 - 2026)
Innate Pharma (IPHA) reported Non-Current Assets of $17.58 million for the quarter ended Jun 30, 2026, down 44.4% from $31.65 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Non-Current Assets (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Innate Pharma posted Non-Current Assets of $18.09 million, down 34.0% from the prior year.
- Non-Current Assets has declined for six consecutive years, with a five-year compound annual growth rate of -34.8% (years ended Dec 2020 to Dec 2025).
- By year, Non-Current Assets came in at $27.4 million in the year ended Dec 31, 2024 (-6.8%), $29.4 million in the year ended Dec 31, 2023 (-53.1%), $62.67 million in the year ended Dec 31, 2022 (-57.6%) and $147.85 million in the year ended Dec 31, 2021 (-3.3%).
- The figure for the quarter ended Jun 30, 2026 ranks as the lowest quarterly Non-Current Assets in data going back to the quarter ended Dec 31, 2017.
- Across the past five years, year-over-year decline in Non-Current Assets ran from 7.4% in the quarter ended Dec 31, 2021 to 59.0% in the quarter ended Dec 31, 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Innate Pharma | 159.32 Mn | 159.32 Mn | - | 17.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.58 Mn |
| Dec 31, 2025 | 18.64 Mn |
| Jun 30, 2025 | 31.65 Mn |
| Dec 31, 2024 | 27.05 Mn |
| Jun 30, 2024 | 42.97 Mn |
| Dec 31, 2023 | 29.24 Mn |
| Jun 30, 2023 | 59.45 Mn |
| Dec 31, 2022 | 60.67 Mn |
| Jun 30, 2022 | 115.92 Mn |
| Dec 31, 2021 | 147.85 Mn |
| Jun 30, 2021 | 164.42 Mn |
| Dec 31, 2020 | 159.73 Mn |
| Jun 30, 2020 | 169.38 Mn |
| Dec 31, 2019 | 181.26 Mn |
| Dec 31, 2018 | 150.18 Mn |
| Dec 31, 2017 | 138.35 Mn |
API Access
Innate Pharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();